Santosh Lamichhane
Has grant
Group Leader-PI, Academy research fellow
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
The Gut microbiome Lipid connection and its early life clinical implications
Open Date: 2024-09-01
Close Date:
Grant: Close
Postdoctoral Reasecher
Open Date: 2019-09-01
Close Date: 2022-08-01
Grant: Close
Bridging metabolomics and medical imaging
Open Date: 2012-07-01
Close Date: 2012-10-01
Articles (6)
Despite extensive efforts, extracting medication exposure information from clinical records remains challenging. To complement this approach, here we show the Global Natural Product Social Molecular Networking (GNPS) Drug Library, a tandem mass spectrometry (MS/MS) based resource designed for drug screening with untargeted metabolomics. This resource integrates MS/MS references of drugs and their metabolites/analogs with standardized vocabularies on their exposure sources, pharmacologic classes, therapeutic indications, and mechanisms of action. It enables direct analysis of drug exposure and metabolism from untargeted metabolomics data, supporting flexible summarization at multiple ontology levels to align with different research goals. We demonstrate its application by stratifying participants in a human immunodeficiency virus (HIV) cohort based on detected drug exposures. We uncover drug-associated alterations in microbiota-derived N -acyl lipids that are not captured when stratifying by self-reported medication use. Overall, GNPS Drug Library provides a scalable resource for empirical drug screening in clinical, nutritional, environmental, and other research disciplines, facilitating insights into the ecological and health consequences of drug exposures. While not intended for immediate clinical decision-making, it supports data-driven exploration of drug exposures where traditional records are limited or unreliable.
Year:
2025
Emerging studies reveal that gut microbes can conjugate diverse amino acids to bile acids, known as microbially conjugated bile acids. However, their regulation and health effects remain unclear. Here, we analyzed early-life microbially conjugated bile acid patterns and their link to islet autoimmunity. We quantified 110 microbial bile acids in 303 stool samples collected longitudinally (3–36 months) from children who developed one or more islet autoantibodies and controls who remained autoantibody-negative. We identified distinct age-dependent trajectories of these bile acid amidates and correlated them with gut microbiome composition. We found that altered levels of ursodeoxycholic and deoxycholic acid conjugates were linked to islet autoimmunity as well as modulated monocyte activation in response to immunostimulatory lipopolysaccharide and Th17/Treg cell balance. These findings suggest that microbially conjugated bile acids influence immune development and type 1 diabetes risk.
Year:
2025
Year:
2025
Introduction Human milk is vital in establishing a healthy infant gut microbiome. Gut microbes and their metabolites are important for host development. However, our understanding of how milk metabolites are connected to the gut microbiome and metabolome in early-life remains limited. We aimed to investigate associations between the human milk metabolome and the gut microbiome in infancy. Methods The fecal and milk samples were collected at 2.5 (n=283), 6 (n=129) and 14 (n=65) months of age. Gut microbiota was analyzed with amplicon sequencing, the gut metabolome was analyzed with gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry, and milk metabolites were analyzed with proton nuclear magnetic resonance. Results Bifidobacterium and other butyrate producers were associated with ethanolamine and methionine level in the milk, in a time-dependent manner. Elevated milk fucosylated oligosaccharide, LNFP-I and caprylate concentrations were positively associated with secondary bile acid levels following the introduction of solid foods. Additionally, acidic oligosaccharides 3-SL and 6-SL were positively associated with long-chain carbohydrates prior to solid food introduction, however negatively associated thereafter. Conclusion Our results highlight that milk metabolites are associated with biologically relevant gut microbial metabolites. Only limited associations were observed between milk composition and the microbiome, which differed between early and late infancy. This suggests milk metabolome may differentially influence microbial metabolism depending on dietary diversity and/or the maturity of the microbiome. Importance It’s essential to raise awareness about breastfeeding and its variety of health benefits. Expanding our understanding of how human milk small molecules with potential bioactivity interact with the gut microbiome can help highlight these positive effects. Exploratory studies of human milk composition with gut microbial metabolites may support achieving this goal. Furthermore, understanding of biological effects of different components in human milk is important, and it can help to develop strategies to ensure optimal growth and development of an infant regardless of the breastfeeding status of the child.
Year:
2025
Despite extensive efforts, extracting information on medication exposure from clinical records remains challenging. To complement this approach, we developed the tandem mass spectrometry (MS/MS) based GNPS Drug Library. This resource integrates MS/MS data for drugs and their metabolites/analogs with controlled vocabularies on exposure sources, pharmacologic classes, therapeutic indications, and mechanisms of action. It enables direct analysis of drug exposure and metabolism from untargeted metabolomics data independent of clinical records. Our library facilitates stratification of individuals in clinical studies based on the empirically detected medications, exemplified by drug-dependent microbiota-derived N -acyl lipid changes in a cohort with human immunodeficiency virus. The GNPS Drug Library holds potential for broader applications in drug discovery and precision medicine.
Year:
2024
Transit time, fluid intake, diet, and overall gut health influence stool consistency. However, the relationships between the gut metabolome (microbial metabolites) and stool consistency in infants and young children remain poorly understood. Here, we analyzed the metabolome and microbiota of 618 stool samples from children aged 2.5 months (n = 360), 6 months (n = 229), 14 months (n = 274), and 30 months (n = 169) from the FinnBrain Birth Cohort Study, and related these data to stool water content and parent-reported stool consistency. Breastfeeding showed the strongest association with both stool consistency and fecal water content. Concentrations of newly identified microbial bile acid amidates were associated with constipation and stool water content, while bile salt hydrolase, an enzyme involved in bile acid deconjugation and conjugation was predicted to be negatively associated with stool water content. In addition, short-chain fatty acids, particularly acetate, were positively associated with stool water content, whereas branched-chain short-chain fatty acids showed negative associations. These findings suggest that longer gut transit time permits more extensive microbial metabolism, including the transformation of bile acid amidates. We also found that microbial taxonomic richness, diversity, and community composition were primarily associated with stool water content, with only weak associations with stool consistency. Overall, our results highlight the importance of documenting stool consistency in fecal metabolomics and microbiome research, and provide new insights into how breastfeeding, microbial metabolism, and gut transit time shape early-life gut development.
Year:
2024
Collaborators (29)
Robin Schmid
co-founder, CSO - Chief Scientific Officer
AMO GmbH
Ulrik Sundekilde
VIP, Associate Professor, Head of Section
Aarhus University
David Wishart
Distinguished Professor
University of Alberta
Prajit Rajkumar
University of California, San Diego
Haoqi Zhao
Assistant Professor
Stanford University
Anna Aatsinki
University of Turku
Manuela Raffatellu
University of California, San Diego
Zachary Burcham
Assistant Professor
University of Tennessee
Mingxun Wang
University of California, Riverside
Corinna Brungs
Senior Scientist
Universität Wien
Libin Xu
Professor
University of Washington
Nicole Avalon
Assistant Professor
University at Buffalo School of Pharmacy and Pharmaceutical Sciences
Ipsita Mohanty
Assistant Professor
Pennsylvania State University
Shirley Tsunoda
skaggs school of pharmacy and pharmaceutical sciences university of california san diego la jolla california usa
Alex Dickens
Head of the Turku Centre for Chemical and Molecular Analytics
University of Turku
Linnea Karlsson
Professor
University of Turku
Teemu Kallonen
Helsinki University Hospital
Tiina Paunio
Research Professor
National Institute for Health and Welfare
Rob Knight
University of California, San Diego
Hasse Karlsson
Professor
University of Turku
Scott L Letendre
Professor
University of California, San Diego
Dylan Ross
Data Scientist
Pacific Northwest National Laboratory
Wout Bittremieux
Assistant Professor
University of Antwerp
Yuichiro Tanaka
Associate staff scientist
Cincinnati Children's Hospital Medical Center
Ronald Ellis
Professor
University of California, San Diego
Laura Perasto
University of Turku
Matej Oresic
Professor of medicine (systems medicine), Professor of biochemistry (metabolomics)
Örebro university
Tommi Vatanen
University of Helsinki
Tomáš Pluskal
Junior Group Leader
Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry
Make your next move.
Prepare your application
Review drafts before you send them.